PATENT CLAIM ANALYSIS

Application Number: 16213574
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "448000"]

Abstract:
Naloxone transdermal delivery devices are provided. Aspects of the naloxone transdermal delivery devices include a matrix comprising a naloxone active agent in a pressure sensitive adhesive and a backing layer. Also provided are methods of making and using the naloxone transdermal delivery devices, as well as kits containing the transdermal delivery devices. The devices, kits and methods of using the same find use in a variety of applications.

Claim (Index 64):
The method according to  claim 23 , wherein the method is a method for the treatment or prevention of pruritus in a subject.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.89744
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13079758', '10744996', '10420428', '15326797', '10835535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.707964292991713
- 35 USC 102 Novelty (BERT): 0.4851292275979534
- Combined Prediction Score: 0.6856807864523371
- Mean Citation Score: 150.372822
- Max Citation Score: 160.78304
- Similarity Product: 108.36764836229324

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test